Addressing the Shortage of GLP-1 RA and Dual GIP/GLP-1 RA-Based Therapies—A Systematic Review by Velimir Altabas, Zrinka Orlović, Maja Baretić

Subjects: “…GLP-1 RA…”
Get full text

Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure by Winston Wang, Danielle Green, Ramzi Ibrahim, Mahmoud Abdelnabi, Hoang Nhat Pham, Beani Forst, Mohamed Allam, Patrick Sarkis, George Bcharah, Juan Farina, Chadi Ayoub, Dan Sorajja, Reza Arsanjani

Subjects: Get full text

The Effects of Glucagon‐Like Peptide‐1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review by Victoria J. Old, Melanie J. Davies, Dimitris Papamargaritis, Pratik Choudhary, Emma L. Watson

Subjects: “…GLP‐1 RA…”
Get full text

Influence of glucagon-like peptide-1 receptor agonists on renal parameters: a meta-analysis of randomized controlled trials by Wenjing Li, Xiaoyan Liang, Na Sun, Daqing Zhang

Subjects: “…GLP-1 RA…”
Get full text

Glucagon-like peptide-1 receptor agonists inhibit the progression of malignant pleural effusion in obese mice by regulating the metabolism of pleural effusion by Ming-Ming Shao, Shu-Feng Dong, Qing-Yu Chen, Rui-Qi Wei, Feng-Shuang Yi

Subjects: Get full text

Incidence of Glaucoma in Type 2 Diabetes Patients Treated With GLP‐1 Receptor Agonists: A Systematic Review and Meta‐Analysis by Maheen Asif, Aliza Asif, Ummi Aiman Rahman, Hanzala Ahmed Farooqi, Oshaz Fatima, Waqar Ali, Uzair Jafar, Mohammed Hammad Jaber

Subjects: Get full text

Efficacy of glucagon-like peptide-1 receptor agonists for prevention of stroke among patients with and without diabetes: A meta-analysis with the SELECT and FLOW trails by Asmita Gera, Fakhar Latif, Vamsikalyan Borra, Sidra Naz, Vivek Mittal, Fathima Shehnaz Ayoobkhan, Tushar Kumar, Zarghoona Wajid, Novonil Deb, Tanisha Prasad, Jishanth Mattumpuram, Vikash Jaiswal

Subjects: “…GLP-1 RA…”
Get full text

Semaglutide to remodel mitochondrial dynamics and mitophagy balance for vascular dementia therapy by Xiaoyan Yang, Peng Feng, Hongxu Zhu, Mingkang Wang, Nan Li, Bo Bai, Yuxiang Sun, Zhongrui Yan, Wenshi Wei, Jie Chang, Christian Hölscher, Wenxian Du

Subjects: “…GLP‐1RA…”
Get full text

Mechanism of glucagon-like peptide-1 receptor agonist in the treatment of obesity and food addiction by LIU Luyao, LI Linwei, WANG Chen, DI Jianzhong

Subjects: “…glp-1ra|obesity|food addiction|mesolimbic dopamine system…”
Get full text

Patients’ experiences with GLP1-RAs – a systematic review by Christoffer Kraul Ibsen, Marius Brostrøm Kousgaard, Sofie Olsen, Ann-Kathrin Lindahl Christiansen, Catharina Thiel Sandholdt, Rasmus Rørth, Gritt Overbeck

Subjects: Get full text

GLP-1 Receptor Agonists: Therapeutic Benefits in Renal Function, Cardiovascular Risk, and Physical Activity - A Systematic Review by Łukasz Karaban, Tadeusz Kuźnieców, Monika Paszkowska, Klaudia Mularczyk, Michał Borawski, Aleksandra Ciuła, Anna Jakubiak, Joanna Miśkiewicz, Patrycja Znamirowska, Magdalena Kupis

Subjects: “…GLP-1 RA…”
Get full text

Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder by Tyler S. Oesterle, Ming-Fen Ho

Subjects: Get full text

Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures by Nicola Riccardo Pugliese, Francesco Paneni, Domenico Tricò, Alessandra Violet Bacca, Nicolò De Biase, Hermann Dalpiaz, Alessandro Mengozzi, Agostino Virdis, Lorenzo Ghiadoni, Stefano Taddei, Reinhold Kreutz, Konstantinos Tsioufis, Stefano Masi

Subjects: Get full text

Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials by Haoyang Guo, Juan Yang, Jihan Huang, Ling Xu, Yinghua Lv, Yexuan Wang, Jiyuan Ren, Yulin Feng, Qingshan Zheng, Lujin Li

Subjects: “…GLP-1RA…”
Get full text

Effects of beinaglutide on visceral fat area and gut microbiota in obesity by Tianshui Liu, Weizheng Liang, Fanghua Xu, Yun Wu, Jun Su, Chaoxi Li, Weidong Ren, Li Shi

Subjects: Get full text

GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Game Charger in the Field? by Georgia Doumani, Panagiotis Theofilis, Vasilis Tsimihodimos, Rigas G. Kalaitzidis

Subjects: “…GLP-1RA…”
Get full text

Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications by Basavana Goudra, Geno J. Merli, Michael Green

Subjects: “…GLP-1RA…”
Get full text

GABA and GLP-1 receptor agonist combination therapy modifies diabetes and Langerhans islet cytoarchitecture in a rat model of Wolfram syndrome by Toomas Jagomäe, Sandra Velling, Tessa Britt Tikva, Varvara Maksimtšuk, Nayana Gaur, Riin Reimets, Allen Kaasik, Eero Vasar, Mario Plaas

Subjects: Get full text

Exploring the Putative Involvement of MALAT1 in Mediating the Beneficial Effect of Exendin-4 on Oleic Acid-Induced Lipid Accumulation in HepG2 Cells by Olfa Khalifa, Sama Ayoub, Abdelilah Arredouani

Subjects: Get full text

The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required by Alan J. Sinclair, Ahmed H. Abdelhafiz

Subjects: Get full text